Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. China Pioneer Pharma Holdings Limited
  6. Summary
    1345   KYG2162L1068

CHINA PIONEER PHARMA HOLDINGS LIMITED

(1345)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-09-30 am EDT
2.210 HKD   -4.74%
09/26China Pioneer Pharma's H1 Profit Surges 78%
MT
09/19China Pioneer Pharma Holdings Limited(SEHK:1345) added to S&P Global BMI Index
CI
09/16China Pioneer Pharma Holdings Limited Announces Management Changes
CI
 SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
2.49(c) 2.56(c) 2.44(c) 2.32(c) 2.21(c) Last
58 000 433 000 128 000 349 000 178 000 Volume
-2.73% +2.81% -4.69% -4.92% -4.74% Change
More quotes
Estimated financial data (e)
Sales 2020 1 332 M 187 M 187 M
Net income 2020 52,4 M 7,37 M 7,37 M
Net cash position 2020 240 M 33,7 M 33,7 M
P/E ratio 2020 18,7x
Yield 2020 15,7%
Sales 2021 1 435 M 202 M 202 M
Net income 2021 143 M 20,0 M 20,0 M
Net cash position 2021 388 M 54,5 M 54,5 M
P/E ratio 2021 11,5x
Yield 2021 7,28%
Capitalization 2 390 M 336 M 336 M
EV / Sales 2020 0,56x
EV / Sales 2021 0,88x
Nbr of Employees 292
Free-Float 30,9%
More Financials
Company
China Pioneer Pharma Holdings Ltd. is an investment holding company principally engaged in the marketing, promotion and sales of pharmaceutical products and medical devices. The Company operates through two business segments. The Ophthalmic Pharmaceutical Products segment is engaged in the sales of ophthalmic pharmaceutical products by provision of channel management services and co-promotion services. The Products... 
Sector
Drug Retailers
Calendar
03/30Earnings Release
More about the company
All news about CHINA PIONEER PHARMA HOLDINGS LIMITED
09/26China Pioneer Pharma's H1 Profit Surges 78%
MT
09/19China Pioneer Pharma Holdings Limited(SEHK:1345) ad..
CI
09/16China Pioneer Pharma Holdings Limited Announces Management Changes
CI
09/16China Pioneer Pharma Holdings Limited Announces Resignation of Luo Chunyi as Chief Exec..
CI
09/09China Pioneer Pharma Proposes Name Change; Shares Rally 14%
MT
08/31China Pioneer Pharma Holdings Limited Announces Interim Dividend for the Six Months End..
CI
08/31China Pioneer Pharma Holdings Limited Reports Earnings Results for the Half Year Ended ..
CI
07/12China Pioneer Pharma Signs $4.5 Million Structured Deposit Agreement
MT
06/28China Pioneer Pharma Signs $149.2 Million Production Line Deal with Dalian Xinxindingnu..
MT
03/31China Pioneer Pharma Holdings Limited Announces Dividend for the Year Ended 31 December..
CI
03/31China Pioneer Pharma Holdings Limited Reports Earnings Results for the Full Year Ended ..
CI
02/23China Pioneer Pharma Arm to Invest Over $4 Million in Chinese Conglomerate
MT
01/18China Pioneer Pharma Holdings Limited commences an Equity Buyback Plan for 126,016,700 ..
CI
2021China Pioneer Pharma Holdings Limited Announces Board Changes
CI
2021China Pioneer Pharma Holdings Limited Resolves to Declare Interim Dividend for the Six ..
CI
More news
News in other languages on CHINA PIONEER PHARMA HOLDINGS LIMITED
09/26Le bénéfice du premier semestre de China Pioneer Pharma bondit de 78 %.
09/16China Pioneer Pharma Holdings Limited annonce des changements de direction
09/16China Pioneer Pharma Holdings Limited annonce la démission de Luo Chunyi en tant que ch..
09/09China Pioneer Pharma propose un changement de nom ; les actions font un bond de 14 %.
08/31China Pioneer Pharma Holdings Limited annonce un dividende intérimaire pour le semestre..
More news
Chart CHINA PIONEER PHARMA HOLDINGS LIMITED
Duration : Period :
China Pioneer Pharma Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA PIONEER PHARMA HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Managers and Directors
Yi Xue Chief Financial Officer
Xin Zhou Li Chairman
Yue Wen Yang Chief Operating Officer & Executive Director
Chi Hung Wong Independent Non-Executive Director
Hong Zhang Independent Non-Executive Director